Very typical numbers for a development-stage biotech company waiting for approvals. Health Canada came gave its approval first, next is FDA. The stock will rip when that happens. The stock has been well managed and has loyal loyal long-term players who hold the big positions. Microcurrent therapy could reverse the effects of type 2 diabetes. This little company is on to something big. It's my favorite microcap by far.
News 
Market Data 
Discover 
